Switching for convenience from first-line injectable treatments to oral treatments in multiple sclerosis: Data from a retrospective cohort study

Mult Scler Relat Disord. 2019 Aug;33:39-43. doi: 10.1016/j.msard.2019.05.015. Epub 2019 May 25.
No abstract available

Keywords: Beta-interferon; Fumaric acid; Glatiramer acetate; Multiple sclerosis; Teriflunomide.

Publication types

  • Letter

MeSH terms

  • Adult
  • Crotonates / therapeutic use*
  • Female
  • Glatiramer Acetate / administration & dosage
  • Glatiramer Acetate / therapeutic use*
  • Humans
  • Hydroxybutyrates
  • Male
  • Middle Aged
  • Multiple Sclerosis / drug therapy*
  • Nitriles
  • Retrospective Studies
  • Toluidines / therapeutic use*
  • Treatment Outcome

Substances

  • Crotonates
  • Hydroxybutyrates
  • Nitriles
  • Toluidines
  • teriflunomide
  • Glatiramer Acetate